Welcome!
ALERT Scheduled Emergency Maintenance
Please note that emergency maintenance will take place tonight between 8:00 PM and 10:00 PM. During this time, some services may be temporarily unavailable, including iLab.
We expect any downtime to be brief and appreciate your understanding as we work to maintain system reliability.
Thank you for your patience.
For support queries or issues using this site, please contact Queen Mary IT Services via the Self Service Portal, Email, or call on 0207 882 8888.
Objective of the Unit: The QMUL Lipid Mediator Unit is a QMUL resource that provides the instrumentation and expertise to investigate endogenous protective mechanisms that may become disregulated in disease with a focus on bioactive lipid mediators (Figure 1).
Overview: The Unit utilizes state of the art Liquid Chromatography Tandem Mass Spectrometry (LC-MS-MS; Figure 2) based techniques to identify and quantify bioactive lipid mediators (LM), their precursors and pathway markers in biological systems. The Unit also utilizes LC-MS-MS based techniques to identify and quantify both known and novel further metabolites for each of the bioactive mediators. Together these provide an insight into the resolution status of the biological system(s) being investigated (e.g. cell incubations, organs, tissues etc), protective pathways that become dysregulated during disease as well as potential novel therapeutic leads.
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Dr. Jesmond Dalli |
Director
|
44 (0) 207 882 5654
|
j.dalli@qmul.ac.uk
|
William Harvey Research Institute
|
